Chieh-I Chen

Title: Chieh-I Chen: Innovator in Cancer Pain Treatment

Introduction

Chieh-I Chen is a notable inventor based in Brooklyn, NY (US). He has made significant contributions to the field of cancer treatment, particularly in methods aimed at alleviating cancer pain. His innovative approach focuses on the use of programmed death 1 (PD-1) inhibitors, which have the potential to improve the quality of life for patients suffering from cancer-related pain.

Latest Patents

Chieh-I Chen holds 1 patent for his work titled "Methods of treating cancer pain by administering a PD-1 inhibitor." This patent outlines methods for treating or inhibiting cancer pain in patients. The process involves selecting a patient with cancer and administering a therapeutically effective amount of a PD-1 inhibitor. Additionally, the patent describes methods for reducing analgesic use in patients already undergoing background analgesic therapy, leading to concurrent tumor regression, pain reduction, and decreased reliance on analgesics.

Career Highlights

Throughout his career, Chieh-I Chen has worked with prominent companies in the biotechnology sector. He has been associated with Regeneron Pharmaceuticals, Inc. and Sanofi Biotechnology, where he has contributed to various research initiatives aimed at improving cancer treatment methodologies.

Collaborations

Chieh-I Chen has collaborated with several professionals in his field, including Medha R Sasane and Denise P Bury-Maynard. These collaborations have likely enhanced his research and development efforts in cancer pain management.

Conclusion

Chieh-I Chen's innovative work in the treatment of cancer pain through PD-1 inhibitors represents a significant advancement in oncology. His contributions not only aim to alleviate pain but also to improve overall patient outcomes.